Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel-Reference-Cited by-同舟云学术

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

Published:2017-01-01 Issue:1 Volume:24 Page:1801-1810
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Steins Anne¹²,Ebbing Eva A.¹²,Pistorius Marcel C. M.³,Waasdorp Cynthia¹,Krishnadath Kausilia K.¹⁴,Medema Jan Paul¹⁵,Wilmink Johanna W.²,Mathôt Ron A. A.³,Bijlsma Maarten F.¹,van Laarhoven Hanneke W. M.²

Affiliation:

1. Cancer Center Amsterdam, Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands;

2. Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands;

3. Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, The Netherlands;

4. Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands;

5. Cancer Genomics Center, Center for Molecular Medicine, Utrecht, The Netherlands

Funder

KWF

Celgene

Novartis

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/10717544.2017.1406559

Reference41 articles.

1. Intestinal barrier in inflammatory bowel disease

2. Bayless TM, Hanauer S. (2011). Advanced therapy of inflammatory disease: Volume 1: IBD and ulcerative colitis. Shelton, CT: People's Medical publishing house. pp. 330.

3. Molecular mechanisms and clinical applications of angiogenesis

4. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer

5. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronidase improves the efficacy of nab-paclitaxel after prolonged angiogenesis inhibition in preclinical models for esophagogastric cancer;Biomedicine & Pharmacotherapy;2024-09

2. XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo;Biochemical Genetics;2024-07-24

3. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial;Nature Communications;2024-01-02

4. Rapid stromal remodeling by short‐term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma;Molecular Oncology;2020-04

5. Multiple cherry angiomas and pyogenic granuloma in a patient treated with ramucirumab and paclitaxel;Indian Journal of Dermatology, Venereology and Leprology;2020